Invesco Ltd. Madrigal Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 120,246 shares of MDGL stock, worth $39.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

120,246

Previous 133,758 10.1%

Holding current value

$39.5 Million

Previous $37.5 Million 31.9%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$212.22 - $292.96 $2.87 Million - $3.96 Million	-13,512 Reduced 10.1%	120,246 $25.5 Million
Q2 2024 Aug 13, 2024	BUY	$193.33 - $291.99 $10.4 Million - $15.6 Million	53,566 Added 66.8%	133,758 $37.5 Million
Q1 2024 May 14, 2024	BUY	$171.37 - $283.23 $12.3 Million - $20.3 Million	71,530 Added 825.79%	80,192 $21.4 Million
Q4 2023 Feb 12, 2024	BUY	$120.4 - $237.13 $187,462 - $369,211	1,557 Added 21.91%	8,662 $2 Million
Q3 2023 Nov 13, 2023	SELL	$146.04 - $225.78 $2.28 Million - $3.52 Million	-15,612 Reduced 68.72%	7,105 $1.04 Million
Q2 2023 Aug 11, 2023	BUY	$203.88 - $312.0 $127,017 - $194,376	623 Added 2.82%	22,717 $5.25 Million
Q1 2023 May 12, 2023	SELL	$231.06 - $307.08 $2.52 Million - $3.34 Million	-10,890 Reduced 33.02%	22,094 $5.35 Million
Q4 2022 Feb 13, 2023	BUY	$58.39 - $296.54 $1.58 Million - $8.01 Million	27,014 Added 452.5%	32,984 $9.57 Million
Q3 2022 Nov 14, 2022	BUY	$60.57 - $79.51 $38,461 - $50,488	635 Added 11.9%	5,970 $388,000
Q2 2022 Aug 15, 2022	BUY	$58.04 - $100.2 $3,540 - $6,112	61 Added 1.16%	5,335 $382,000
Q1 2022 May 16, 2022	SELL	$55.89 - $101.89 $100,937 - $184,013	-1,806 Reduced 25.51%	5,274 $518,000
Q4 2021 Feb 14, 2022	SELL	$72.34 - $95.09 $41,233 - $54,201	-570 Reduced 7.45%	7,080 $600,000
Q3 2021 Nov 15, 2021	BUY	$78.35 - $105.02 $69,104 - $92,627	882 Added 13.03%	7,650 $610,000
Q2 2021 Aug 17, 2021	BUY	$97.2 - $137.59 $220,449 - $312,054	2,268 Added 50.4%	6,768 $659,000
Q1 2021 May 17, 2021	BUY	$108.54 - $125.2 $45,803 - $52,834	422 Added 10.35%	4,500 $527,000
Q4 2020 Feb 16, 2021	BUY	$110.06 - $133.7 $115,232 - $139,983	1,047 Added 34.54%	4,078 $454,000
Q3 2020 Nov 16, 2020	SELL	$99.78 - $124.21 $5,188 - $6,458	-52 Reduced 1.69%	3,031 $360,000
Q2 2020 Aug 14, 2020	SELL	$60.13 - $125.71 $10,763 - $22,502	-179 Reduced 5.49%	3,083 $349,000
Q1 2020 May 15, 2020	BUY	$66.76 - $93.49 $217,771 - $304,964	3,262 New	3,262 $217,000
Q3 2019 Nov 14, 2019	SELL	$84.4 - $106.53 $5.65 Million - $7.13 Million	-66,896 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$91.13 - $142.5 $3.74 Million - $5.85 Million	41,083 Added 159.16%	66,896 $7.01 Million
Q1 2019 May 15, 2019	BUY	$103.48 - $143.84 $2.67 Million - $3.71 Million	25,813 New	25,813 $3.23 Million

Others Institutions Holding MDGL

# of Institutions

295

Shares Held

21.9M

Call Options Held

819K

Put Options Held

644K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.61B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account